Literature DB >> 15280303

Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov.

Enrico Tortoli1, Laura Rindi2, Maria J Garcia3, Patrizia Chiaradonna4, Rosanna Dei5, Carlo Garzelli2, Reiner M Kroppenstedt6, Nicoletta Lari2, Romano Mattei7, Alessandro Mariottini8,1, Gianna Mazzarelli9,1, Martha I Murcia3, Anna Nanetti10, Paola Piccoli11, Claudio Scarparo11.   

Abstract

The possibility that the strains included within the Mycobacterium avium complex (MAC), but not belonging either to M. avium or to Mycobacterium intracellulare, may be members of undescribed taxa, has already been questioned by several taxonomists. A very homogeneous cluster of 12 strains characterized by identical nucleotide sequences both in the 16S rDNA and in the 16S-23S internal transcribed spacer was investigated. Similar strains, previously reported in the literature, had been assigned either to the species M. intracellulare on the basis of the 16S rDNA similarity or to the group of MAC intermediates. However, several phenotypical and epidemiological characteristics seem to distinguish these strains from all other MAC organisms. The unique mycolic acid pattern obtained by HPLC is striking as it is characterized by two clusters of peaks, instead of the three presented by all other MAC organisms. All of the strains have been isolated from humans and all but one came from the respiratory tract of elderly people. The clinical significance of these strains, ascertained for seven patients, seems to suggest an unusually high virulence. The characteristics of all the strains reported in the literature, genotypically identical to the ones described here, seem to confirm our data, without reports of isolations from animals or the environment or, among humans, from AIDS patients. Therefore, an elevation of the MAC variant was proposed and characterized here, with the name Mycobacterium chimaera sp. nov.; this increases the number of species included in the M. avium complex. The type strain is FI-01069T (=CIP 107892T=DSM 44623T).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280303     DOI: 10.1099/ijs.0.02777-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  82 in total

1.  Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing.

Authors:  Ailyn C Pérez-Osorio; David S Boyle; Zachary K Ingham; Alla Ostash; Romesh K Gautom; Craig Colombel; Yolanda Houze; Brandon T Leader
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

Review 2.  Sequence-based identification of new bacteria: a proposition for creation of an orphan bacterium repository.

Authors:  M Drancourt; D Raoult
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Use of microelectronic array technology for rapid identification of clinically relevant mycobacteria.

Authors:  Maurizio Sanguinetti; Linda Novarese; Brunella Posteraro; Stefania Ranno; Elena De Carolis; Giovanni Pecorini; Barbara Lucignano; Fausta Ardito; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

4.  Evaluation of the new GenoType Mycobacterium assay for identification of mycobacterial species.

Authors:  Cristina Russo; Enrico Tortoli; Donato Menichella
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

5.  Direct identification of mycobacteria in primary liquid detection media by partial sequencing of the 65-kilodalton heat shock protein gene.

Authors:  Alan McNabb; Kathy Adie; Mabel Rodrigues; William A Black; Judith Isaac-Renton
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

6.  Utility of rpoB gene sequencing for identification of nontuberculous mycobacteria in the Netherlands.

Authors:  Rina de Zwaan; Jakko van Ingen; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

7.  Drug susceptibility distributions of Mycobacterium chimaera and other non-tuberculous mycobacteria.

Authors:  Bettina Schulthess; Daniel Schäfle; Nicole Kälin; Tamara Widmer; Peter Sander
Journal:  Antimicrob Agents Chemother       Date:  2021-02-22       Impact factor: 5.191

8.  Commercial DNA probes for mycobacteria incorrectly identify a number of less frequently encountered species.

Authors:  Enrico Tortoli; Monica Pecorari; Giuliana Fabio; Massimino Messinò; Anna Fabio
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

9.  Absence of Mycobacterium intracellulare and presence of Mycobacterium chimaera in household water and biofilm samples of patients in the United States with Mycobacterium avium complex respiratory disease.

Authors:  Richard J Wallace; Elena Iakhiaeva; Myra D Williams; Barbara A Brown-Elliott; Sruthi Vasireddy; Ravikiran Vasireddy; Leah Lande; Donald D Peterson; Janet Sawicki; Rebecca Kwait; Wellington S Tichenor; Christine Turenne; Joseph O Falkinham
Journal:  J Clin Microbiol       Date:  2013-03-27       Impact factor: 5.948

10.  Prosthetic valve endocarditis and bloodstream infection due to Mycobacterium chimaera.

Authors:  Yvonne Achermann; Matthias Rössle; Matthias Hoffmann; Vanessa Deggim; Stefan Kuster; Dieter R Zimmermann; Guido Bloemberg; Michael Hombach; Barbara Hasse
Journal:  J Clin Microbiol       Date:  2013-03-27       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.